Drug intelligence / Profile preview

choline + aspirin

Development stage
Preclinical
Lead developer
Aspire Biopharma
Modality
Small Molecules
Administration
Oral (studied), Intravenous (studied)
01

Overview

Choline + aspirin is a combination of two agents—choline, an essential nutrient and α7 nicotinic receptor agonist, and aspirin (acetylsalicylic acid), a non-steroidal anti-inflammatory drug (NSAID). This combination has been studied for its synergistic analgesic effects in inflammatory pain models. Choline itself exhibits antinociceptive properties via activation of α7 nicotinic receptors, muscarinic receptors, and opioid receptors. When coadministered with aspirin, the combination demonstrates enhanced potency and duration of analgesia compared to either agent alone. The mechanism involves both central and peripheral pathways for pain modulation. While not currently marketed as a fixed-dose pharmaceutical product, this combination is under investigation as a potential safe analgesic regimen for inflammatory pain[2].

02

Targets

CHRNA7 (α7 nicotinic receptor)mAChR (Muscarinic acetylcholine receptors)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on choline + aspirin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline + aspirin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call